A Multicentric, Non-interventional Study on Switching From Oral Parkinson Therapy to Neupro® in Patients With Idiopathic Parkinson's Disease With Gastrointestinal Symptoms
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2015
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms NON-GI
- Sponsors UCB
- 19 Mar 2013 Results have been presented at the 65th American Academy of Neurology Annual Meeting (AAN-2013) according to a UCB media release. Results were also summarised in the media release.
- 30 Apr 2012 Actual patient number is 76 according to ClinicalTrials.gov.
- 27 Apr 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.